# OM336 in Autoimmune Cytopenias

> **NCT07083960** · PHASE1 · RECRUITING · sponsor: **Ouro Medicines** · enrollment: 32 (estimated)

## Conditions studied

- AIHA - Warm Autoimmune Hemolytic Anemia
- AIHA - Cold Autoimmune Hemolytic Anemia
- ITP - Immune Thrombocytopenia

## Interventions

- **DRUG:** OM336

## Key facts

- **NCT ID:** NCT07083960
- **Lead sponsor:** Ouro Medicines
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2026-12
- **Final completion:** 2027-09
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2025-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07083960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07083960, "OM336 in Autoimmune Cytopenias". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT07083960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*